Nuclear Medicine
FLPET (R+D)
Name:
FLPET (R&D)
Active Principle:
3´-DEOXI-3-(18F)-FLUORTHIMIDINE
Therapeutic Action:
It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness of tumors such as Astrocytoma, glioblastoma multiforme, medulloblastoma, oligogastrocytoma, ganglioma, lung cancer, colorectal carcinoma, malignant melanoma, Non-Hodgkin’s lymphoma, breast cancer and pancreatic ductal adenocarcinoma.
Nuclear Medicine
FLPET (R+D)
Name:
FLPET (R&D)
Active Principle:
3´-DEOXI-3-(18F)-FLUORTHIMIDINE
Therapeutic Action:
It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness of tumors such as Astrocytoma, glioblastoma multiforme, medulloblastoma, oligogastrocytoma, ganglioma, lung cancer, colorectal carcinoma, malignant melanoma, Non-Hodgkin’s lymphoma, breast cancer and pancreatic ductal adenocarcinoma.
